JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
 QUICK SEARCH:   [advanced]


     


J Am Coll Cardiol, 1999; 34:1420-1426
© 1999 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Neumann, F.-J.
Right arrow Articles by Schömig, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Neumann, F.-J.
Right arrow Articles by Schömig, A.

Effect of glycoprotein IIb/IIIa receptor blockade on platelet-leukocyte interaction and surface expression of the leukocyte integrin Mac-1 in acute myocardial infarction

Franz-Josef Neumann, MDa, Dietlind Zohlnhöfer, MDa, Leila Fakhoury, MDa, Ilka Ott, MDa, Meinrad Gawaz, MDa and Albert Schömig, MDa

a Deutsches Herzzentrum and 1. Medizinische Klinik der Technischen Universität München, Munich, Germany



View larger version (24K):

[in a new window]
 
Figure 1 Percentage of monocytes with GP Ib{alpha} fluorescence signal (left panel) and GP Ib{alpha} fluorescence intensity (arbitrary units) (right panel) of GP Ib{alpha}-positive monocytes in whole blood at baseline (control) and after stimulation in vitro with 20 µmol/L ADP in the presence or absence of blocking anti-P-selectin mAbs or of abciximab. *p < 0.01 for the comparison to ADP-stimulated whole blood without mAbs. GP = glycoprotein; mAbs = monoclonal antibodies.

 


View larger version (145K):

[in a new window]
 
Figure 2 Confocal laser microscopic images (upper panels) and corresponding P-selectin fluorescence images (lower panels) of platelet-leukocyte aggregates after in vitro stimulation of whole blood with 20 µmol/L ADP in the presence or absence of abciximab.

 


View larger version (41K):

[in a new window]
 
Figure 3 Mac-1 fluorescence intensity of leukocytes with platelets attached (GP Ib{alpha} +) of platelet-negative leukocytes (GP Ib{alpha} –) in the monocyte population and in the entire population of myeloid leukocytes (All). GP = glycoprotein.

 


View larger version (14K):

[in a new window]
 
Figure 4 Overall GP Ib{alpha} fluorescence intensity (arbitrary units) of monocytes in patients assigned to heparin treatment (closed circles) and in patients assigned to abciximab (open circles). Circles represent median and error bars interquartile range. *p < 0.002 for the comparison between groups. p Values for the comparison with the initial value in each treatment group are given at the bottom and at the top of the graphs. GP = glycoprotein.

 


View larger version (14K):

[in a new window]
 
Figure 5 Mac-1 fluorescence intensity (arbitrary units) of monocytes in patients assigned to heparin treatment (closed circles) and in patients assigned to abciximab (open circles). Circles represent median and error bars interquartile range. *p < 0.004 for the comparison between groups. p Values for the comparison with the initial value in each treatment group are given at the bottom and at the top of the graph.

 





HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 1999 by the American College of Cardiology Foundation.